EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access

Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials

Jung-Hee Lee, Jaeoh Lee, Su Yong Kim, Ho Sung Jeon, Jun-Won Lee, Sung Gyun Ahn, Yong-Joon Lee, Seung-Jun Lee, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko und 5 weitere

EuroIntervention · 2026-02 · 22 (4) · 232-242

DOI: 10.4244/eij-d-25-00832 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift EuroIntervention, 2026-02. Verfasst von Jung-Hee Lee und 16 weiteren Autor:innen. Beteiligte Einrichtung: Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Ticagrelor, Aspirin, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ticagrelor monotherapy following abbreviated dual antiplatelet therapy (DAPT) is an emerging strategy for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). However, the timing of aspirin discontinuation has not been directly compared in this setting. AIMS: We aimed to compare the clinical outcomes of aspirin discontinuation within 1 month versus at 3 months after PCI in patients with ACS. METHODS: This post hoc analysis used individual patient-level data from the TICO and T-PASS trials, which exclusively enrolled patients with ACS undergoing PCI. Of 2,953 patients who received ticagrelor monotherapy after abbreviated DAPT, 1,426 discontinued aspirin within 1 month and 1,527 at 3 months. After propensity score matching, 2,248 patients were included in the final analysis. The primary endpoint was a composite of all-cause death, myocardial infarction, stent thrombosis, ischaemia-driven target vessel revascularisation, stroke, and major bleeding at 1 year. RESULTS: The primary endpoint occurred less frequently in the

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeTicagrelorAspirinPlatelet Aggregation InhibitorsPercutaneous Coronary InterventionHumansMaleFemaleAgedTreatment OutcomeMiddle AgedTime FactorsHemorrhageMyocardial InfarctionTreatment Interruption

Substanzen

TicagrelorAspirinPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Cardiology, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, Republic of Korea.

Zitieren

APA

Lee, J. H., Lee, J., Kim, S. Y., Jeon, H. S., Lee, J. W., Ahn, S. G., Lee, Y. J., Lee, S. J., Ahn, C. M., Kim, J. S., Kim, B. K., Ko, Y. G., Choi, D., Hong, M. K., Jang, Y., Hong, S. J., & Youn, Y. J. (2026). Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials. EuroIntervention, 22(4), 232-242. https://doi.org/10.4244/eij-d-25-00832

Vancouver

Lee JH, Lee J, Kim SY, Jeon HS, Lee JW, Ahn SG, et al. Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials. EuroIntervention. 2026;22(4):232-242. doi:10.4244/eij-d-25-00832

BibTeX
@article{Lee2026,
  author = {Lee, Jung-Hee and Lee, Jaeoh and Kim, Su Yong and Jeon, Ho Sung and Lee, Jun-Won and Ahn, Sung Gyun and Lee, Yong-Joon and Lee, Seung-Jun and Ahn, Chul-Min and Kim, Jung-Sun and Kim, Byeong-Keuk and Ko, Young-Guk and Choi, Donghoon and Hong, Myeong-Ki and Jang, Yangsoo and Hong, Sung-Jin and Youn, Young Jin},
  title = {Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials},
  journal = {EuroIntervention},
  year = {2026},
  volume = {22},
  number = {4},
  pages = {232--242},
  doi = {10.4244/eij-d-25-00832}
}
Kostenlos starten →